Our sites understand the complexities of CNS trials and have expertise in neurology, psychiatry and sleep disorder studies.

Central Nervous System (CNS) disorders represent a significant percentage of ongoing clinical trials, due to a combination of unmet need and market potential. Yet these studies are highly complex, progress relatively slowly through clinical development and regulatory review, and have lower than average success rates in clinical development due to their often subjective endpoints and a high rate of placebo effects. Because of these complexities and challenges, it is important to select investigators that understand the CNS clinical trial process and have experience treating these highly specialized patient populations.

The Elite Research Network includes investigators board certified in:

Sleep Medicine
Nuclear Medicine

As well as general practitioners. We also have psychiatry raters with experience in cognitive testing scales including ADHD-RS, BCME, Conner’s Patient Rating Scale, HAM A and HAM D. Our Sleep Medicine sites have not only investigators and study coordinators but registered sleep technicians, scorers and raters, as well as state-of-the-art sleep labs equipped with polysomnography (with and without CPAP), multiple sleep latency testing, and maintenance of wakefulness.

Collectively, we have conducted hundreds of CNS trials in neurology, psychiatry, and sleep medicine from Phase I through Phase IV. Each of our sites utilizes a central IRB to accelerate study start up. Through a combination of our patient databases and selective advertising, our sites typically meet or exceed enrollment goals in the CNS studies we conduct, while providing high quality data to our clients.

Due to our therapeutic expertise in CNS, we work with our clients in the feasibility and planning stages of their studies. We offer focus groups consisting of investigators, study coordinators, and when appropriate, study participants, in order to establish enrollment expectations and address potential challenges in an effort to minimize cost to the client.


Our sites have successfully conducted the following neurology studies:
  • Alzheimer's Disease
  • Dementia
  • Diabetic Neuropathy
  • Epilepsy / Seizures
  • Headaches
  • Migraines
  • Mild Cognitive Impairment
  • Multiple Sclerosis
  • Parkinson's Disease
  • Peripheral Neuropathic Pain
  • Stroke


Our sites have successfully conducted the following psychiatry studies:
  • Alcoholism
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Anorexia
  • Anxiety
  • Bipolar
  • Depression
  • Eating Disorders
  • Obsessive-Compulsive Disorder (OCD)
  • Panic Disorder
  • Post-Traumatic Stress Disorder
  • Schizophrenia
  • Smoking Cessation

Sleep Medicine

Our sites have successfully conducted the following sleep related studies:
  • Circadian Rhythm Sleep Disorders
  • Insomnia (chronic and transient; in-patient and out-patient)
  • Jet Lag
  • Narcolepsy
  • Restless Leg Syndrome
  • Shift Work Syndrome
  • Sleep Apnea
  • Sleep Wake Disorder

Contact us for a complete list of CNS enrollment metrics.

Find the right sites for your clinical program, right from
the start.
Call us: (843) 607-2933  |  email us:  |  follow us:    
Company            Investigator Sites            Therapeutic Expertise            Services            Phase I - IV            Library            News & Events            Contact